Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress.
about
Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalIdentification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting5-Fluorouracil nanoparticles inhibit hepatocellular carcinoma via activation of the p53 pathway in the orthotopic transplant mouse modelFatty acyl moieties: improving Pro-rich peptide uptake inside HeLa cells.Analytical model of magnetic nanoparticle transport and capture in the microvasculature.Nanoscale magnetic biotransport with application to magnetofection.Nanoparticle design optimization for enhanced targeting: Monte Carlo simulations.LFA-1 on leukemic cells as a target for therapy or drug delivery.Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.Enhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with Luteinizing Hormone-Releasing Hormone (LHRH) peptide.Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agentCPP2-p16MIS treatment-induced colon carcinoma cell death in vitro and prolonged lifespan of tumor-bearing mice.In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting.Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours.Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.Preliminary pharmacology of galactosylated chitosan/5-fluorouracil nanoparticles and its inhibition of hepatocellular carcinoma in miceMicrofluidic platform for photodynamic therapy cytotoxicity analysis of nanoencapsulated indocyanine-type photosensitizers.Design and Application of Magnetic-based Theranostic Nanoparticle SystemsNanovehicular intracellular delivery systems.Chemotherapy drug delivery from calcium phosphate nanoparticles.Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapyExploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug deliverySynthesis of liver-targeting dual-ligand modified GCGA/5-FU nanoparticles and their characteristics in vitro and in vivoOptimized synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and their characteristics.Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapyThe rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.Targeted photodynamic therapy--a promising strategy of tumor treatment.Image-guided nanosystems for targeted delivery in cancer therapy.Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.Novel therapy based on camelid nanobodies.Magnetic therapeutic delivery using navigable agents.Polymeric biomaterials for the delivery of platinum-based anticancer drugs.Self-Assembled Smart Nanocarriers for Targeted Drug Delivery.Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?Polymer-Coated Magnetic Nanoparticles for Curcumin Delivery to Cancer Cells.Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles.Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumor in vivo.Nanoparticles exposing neurotensin tumor-specific drivers.
P2860
Q26744536-D45D57C8-CFA9-4782-9B31-EF89A33B6746Q28475666-D5511818-B4B0-4627-82EE-C8F727890790Q28484409-A7EF9713-A59F-4917-A4F5-92568F10A80EQ33214906-F3ACACF9-D64E-4C68-9CBE-6683DE4A2915Q33253801-DEE4BB15-721F-42D5-91B7-ED3991CECEF5Q33353509-4CA99CAA-A81D-454D-A1F7-3555486D1418Q34391939-A395AD00-0677-4B88-847A-43C593A5888FQ34394850-8DEEC3ED-F174-475F-A1A4-E51945C384E7Q35136562-0F5DF4A7-D28D-48FD-9DBF-158BF3AA4962Q35157103-FF0A15D7-8F42-4C30-8A78-93E8D92FDC3FQ35162175-C98D0569-7CD8-451C-8102-80AFA7C27FA5Q35972562-95BE7A24-FE5C-4437-AC7C-37DB55511CDFQ36093248-7839C4FA-0ABA-45D8-8785-EF0D3FEF63F0Q36237892-51F66B02-D103-4EF6-87E5-C876A284FC83Q36327049-17DAC652-8506-4483-8A36-0EB293ECB039Q36395355-DA84B91D-2075-42C1-890E-12DEBEE17DE4Q36524207-2683767A-6790-4BAC-B9C9-C5EE8430C2EAQ36576923-BBC6F7EE-83A8-47B4-92AF-99DBA2F5658CQ36940177-F1DAAF4A-4838-4B40-AE56-30F47632ADA0Q37058812-0495F447-9CF7-495D-AB14-F7B3F9D78EFFQ37178507-C880795B-A903-4FB6-9899-632F125757A3Q37194020-C6215CD1-3502-42F8-AC4C-B9B560103CE9Q37207271-1E6FBB52-F799-4D67-A5E3-7CB06EEE0F72Q37305848-30E3EF72-24CA-4374-887B-F210211F0E99Q37537829-760F1F65-BD64-4405-A2E9-96D016AF5626Q37624281-94577525-1D51-4692-AB07-02C0D614A5B1Q37815479-F469880D-3362-4B36-8FF7-5AE621DC12CDQ37872626-4F162D1F-0026-44B3-BCEF-394D2FBF9696Q38011794-4F104340-8F64-4EEF-99C4-63039DAFB2FCQ38032893-9B3F82F4-6404-458A-855B-4320076CCC1AQ38151739-E5E7C9FD-AB0A-4333-B920-A5BB96FB0AA0Q38183854-CE0E9D47-42C3-4043-9586-6D78C3B7E3B6Q38556758-9B3F3B10-B0E3-48EB-AE1F-B9E663E4304FQ38599130-9E19A49C-7752-430A-9419-10FD58DA5F0FQ38806793-9D622ECE-4F85-4D20-86D1-20F8AE47A533Q38862836-A4CE962E-A368-4139-A04E-9F6347DF6938Q38883410-4FC78AAD-BB20-4436-AC08-E6AA0CDAB2E9Q38998571-B5978CF6-7958-4516-A202-0DC88D6BC1B8Q39144516-2F2E5A9C-696D-4551-9B96-A45BCFD5E023Q39189330-D1BA5D12-AA30-4439-83E0-27F11A70305A
P2860
Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Active targeting with particul ...... damentals and recent progress.
@ast
Active targeting with particul ...... damentals and recent progress.
@en
type
label
Active targeting with particul ...... damentals and recent progress.
@ast
Active targeting with particul ...... damentals and recent progress.
@en
prefLabel
Active targeting with particul ...... damentals and recent progress.
@ast
Active targeting with particul ...... damentals and recent progress.
@en
P1433
P1476
Active targeting with particul ...... damentals and recent progress.
@en
P2093
Fabrizio Marcucci
François Lefoulon
P304
P356
10.1016/S1359-6446(03)02988-X
P577
2004-03-01T00:00:00Z